Fresenius Medical Care AG (FMS) Cash from Investing Activities (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Cash from Investing Activities for 17 consecutive years, with $678.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 10.93% year-over-year to $678.6 million; the TTM figure through Dec 2025 stood at $340.8 million (down 57.04% YoY), while the FY2025 annual figure was $2.3 billion, down 7.31% from the prior year.
• Cash from Investing Activities came in at $678.6 million for Q4 2025 at Fresenius Medical Care AG, up from -$63.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $761.9 million in Q4 2024, with the low at -$354.1 million in Q3 2021.
• Average Cash from Investing Activities over 5 years is $25.5 million, with a median of -$129.5 million recorded in 2023.
• Across the five-year window, Cash from Investing Activities surged 339.22% in 2024 and slumped 146.29% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at $281.4 million in 2021, then soared by 35.95% to $382.6 million in 2022, then soared by 75.2% to $670.3 million in 2023, then gained by 13.67% to $761.9 million in 2024, then declined by 10.93% to $678.6 million in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $678.6 million, -$63.1 million, and -$160.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.